A November 2025 KFF Health Tracking Poll found that about one in eight U.S
Gastrointestinal symptoms such as nausea, constipation, and indigestion are most common and usually subside as your body adjusts
In 2026, we understand that true, sustainable weight loss isn't found in a one-size-fits-all bottle from a retail shelf
But in individuals who are body-aware or prone to health anxiety, even a small increase in resting heart rate can trigger anxiety about cardiac health, which produces more anxiety, which further elevates heart rate, creating a self-reinforcing cycle
Federal health policy also has been slow to respond: The outgoing Biden administration proposed coverage of GLP-1s for weight loss by Medicare and Medicaid in November of 2024
On the other hand, Semaglutide is FDA-approved for weight management and type 2 diabetes